Literature DB >> 15923509

Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy.

A Boschi1, Ch Daumerie, M Spiritus, C Beguin, M Senou, D Yuksel, M Duplicy, S Costagliola, M Ludgate, M C Many.   

Abstract

BACKGROUND/AIM: Thyroid associated orbitopathy (TAO) and Graves' disease (GD) have an autoimmune pathogenesis, possibly related to the thyrotropin receptor (TSHR). The aim of this study was to determine whether TSHR immunoreactivity is correlated with disease severity or serum TSHR antibody (TRAB) levels.
METHODS: Orbital tissues from 30 patients with TAO were compared with those of 20 patients with strabismus and four with non-thyroid orbital inflammation. TSHR was detected by immunohistochemistry and TRAB were measured by radioreceptor assay.
RESULTS: No TSHR immunoreactivity was detected in the 24 control orbital tissues, whereas in all TAO biopsies elongated fibroblast-like cells, expressing TSHR, were present. These cells were located between the muscle cells, which were separated by oedema in the acute phase but fibrous tissue in the chronic phase of disease. Semi-thin sections showed numerous mast cells present in the chronic phase and in close contact with adipocytes. The number of TSHR immunostained cells was high in early disease, decreased with disease duration, and was positively correlated with TRAB levels at the onset of TAO.
CONCLUSION: TSHR immunoreactivity was demonstrated specifically in TAO orbits which highlights the importance of TRAB early in the pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923509      PMCID: PMC1772662          DOI: 10.1136/bjo.2004.050807

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  25 in total

Review 1.  Graves' disease is a multi-system autoimmune disorder in which extra ocular muscle damage and connective tissue inflammation are variable features.

Authors:  Jack R Wall
Journal:  Thyroid       Date:  2002-01       Impact factor: 6.568

2.  Ocular changes in Graves' disease. A long-term follow-up study.

Authors:  I B HALES; F F RUNDLE
Journal:  Q J Med       Date:  1960-01

3.  The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.

Authors:  D H Khoo; S C Ho; L L Seah; K S Fong; E S Tai; S P Chee; P H Eng; S E Aw; A C Fok
Journal:  Thyroid       Date:  1999-12       Impact factor: 6.568

4.  Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.

Authors:  A Pinchera; P Liberti; E Martino; G F Fenzi; L Grasso; L Rovis; L Baschieri; G Doria
Journal:  J Clin Endocrinol Metab       Date:  1969-02       Impact factor: 5.958

5.  Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.

Authors:  G Fenzi; K Hashizume; C P Roudebush; L J DeGroot
Journal:  J Clin Endocrinol Metab       Date:  1979-04       Impact factor: 5.958

6.  Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts.

Authors:  A Bell; A Gagnon; L Grunder; S J Parikh; T J Smith; A Sorisky
Journal:  Am J Physiol Cell Physiol       Date:  2000-08       Impact factor: 4.249

7.  Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.

Authors:  S Costagliola; M C Many; J F Denef; J Pohlenz; S Refetoff; G Vassart
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

8.  Adipogenesis in thyroid eye disease.

Authors:  M Crisp; K J Starkey; C Lane; J Ham; M Ludgate
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

9.  Extrathyroidal manifestations of Graves' disease: the thyrotropin receptor is expressed in extraocular, but not cardiac, muscle tissues.

Authors:  B E Busuttil; A G Frauman
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

10.  Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.

Authors:  M N Gerding; J W van der Meer; M Broenink; O Bakker; W M Wiersinga; M F Prummel
Journal:  Clin Endocrinol (Oxf)       Date:  2000-03       Impact factor: 3.478

View more
  16 in total

1.  Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis).

Authors:  Don O Kikkawa
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

2.  Expression of TSH-R in normal human extraocular muscles.

Authors:  S J Kloprogge; A G Frauman
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

Review 3.  Graves orbitopathy: a perspective.

Authors:  Petros Perros; Gerasimos E Krassas
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

4.  Perimysial fibroblasts of extraocular muscle, as unique as the muscle fibers.

Authors:  Linda L Kusner; Andrew Young; Steven Tjoe; Patrick Leahy; Henry J Kaminski
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

5.  Biomarker identification of thyroid associated ophthalmopathy using microarray data.

Authors:  Hong-Bin Yang; Jie Jiang; Lu-Lu Li; Huang-Qiang Yang; Xiao-Yu Zhang
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

6.  Usefulness of TSH receptor antibodies as biomarkers for Graves' ophthalmopathy: a systematic review.

Authors:  S Seo; M Sánchez Robledo
Journal:  J Endocrinol Invest       Date:  2018-09-07       Impact factor: 4.256

7.  Thyroid-associated orbitopathy is linked to gastrointestinal autoimmunity.

Authors:  K A Ponto; D Schuppan; I Zwiener; H Binder; A Mirshahi; T Diana; S Pitz; N Pfeiffer; G J Kahaly
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

Review 8.  Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy.

Authors:  Y P Hai; A C H Lee; L Frommer; T Diana; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2019-09-19       Impact factor: 4.256

Review 9.  Selenium supplementation in thyroid associated ophthalmopathy: an update.

Authors:  Aruna Dharmasena
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

10.  Functional expression of the thyrotropin receptor in C cells: new insights into their involvement in the hypothalamic-pituitary-thyroid axis.

Authors:  Jesús Morillo-Bernal; José M Fernández-Santos; José C Utrilla; Manuel de Miguel; Rocío García-Marín; Inés Martín-Lacave
Journal:  J Anat       Date:  2009-06-01       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.